canephron N

approved as a herbal medicinal product in 28 countries; coated tablet containing centaury powder (Centaurii herba), lovage root powder (Levistici radix) and rosemary leaf powder (Rosmarini folium).

Also Known As:

Networked: 20 relevant articles (3 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Davidov, M I: 3 articles (05/2022 - 10/2018)
2.	Miotla, Pawel: 2 articles (10/2020 - 01/2018)
3.	Rechberger, Tomasz: 2 articles (10/2020 - 01/2018)
4.	Wawrysiuk, Sara: 2 articles (10/2020 - 01/2018)
5.	Abramov-Sommariva, Dimitri: 2 articles (01/2020 - 01/2018)
6.	Naber, Kurt G: 2 articles (01/2020 - 01/2018)
7.	Steindl, Hubert: 2 articles (01/2020 - 01/2018)
8.	Wagenlehner, Florian M: 2 articles (01/2020 - 01/2018)
9.	Bunova, N E: 2 articles (12/2019 - 10/2018)
10.	Amosov, A V: 2 articles (06/2019 - 09/2012)

Related Diseases

1.	Cystitis 10/01/2018 - "The findings of the study show that Canephron N is an effective and safe alternative to treating mild forms (ACSS score less or equal 10) of acute uncomplicated cystitis in women, allowing the use of antibiotics to be reduced. " 10/01/2018 - "A prospective, randomized study of Canephron N and ciprofloxacin for treating mild forms of acute uncomplicated cystitis (ACSS score less or equal 10) comprising 160 women aged 18-55 years was conducted from 2015 to 2017. " 10/01/2018 - "The study aimed to compare the efficacy and safety of Canephron N and ciprofloxacin as monotherapy in the management of mild forms of acute uncomplicated cystitis in women of working age. " 10/01/2018 - "[Comparative assessment of Canephron N and ciprofloxacin as monotherapy of acute uncomplicated cystitis in women]." 12/01/2019 - "According to the results, Canephron N is an effective and safe drug as monotherapy for acute uncomplicated cystitis, and can be considered as drug of choice for the treatment of women with antibiotic allergy or intolerance."
2.	Hypersensitivity (Allergy) 12/01/2019 - "According to the results, Canephron N is an effective and safe drug as monotherapy for acute uncomplicated cystitis, and can be considered as drug of choice for the treatment of women with antibiotic allergy or intolerance." 12/01/2019 - "A prospective, randomized, controlled study of drug Canephron N as monotherapy for acute uncomplicated cystitis in 51 women with a history of antibiotic allergy or intolerance was carried out in 3 urological centers in Perm from 2016 to 2019. " 12/01/2019 - "A comparative evaluation of the efficacy and safety of Canephron N and Cystone as monotherapy in women with acute uncomplicated cystitis and antibiotic allergy or intolerance was performed. "
3.	Pyelonephritis 01/01/2018 - "Adverse event rates were similar between groups, with higher rates of gastrointestinal disorders in the FT group and pyelonephritis in the BNO 1045 group. " 05/01/2022 - "The inclusion of long-term phytotherapy with Canephron N in the treatment regimen increased the effectiveness of treatment, improved kidney function in patients, significantly reduced the number of pregnant women with leukocyturia and bacteriuria, and reduced the risk of a repeated attack of pyelonephritis." 07/01/2018 - "In the group of antibiotic therapy, one patient developed cystitis and three had pyelonephritis; in the Canephron N group, cystitis occurred in one patient, no pyelonephritis cases were observed. "
4.	Bacteriuria 05/01/2022 - "The inclusion of long-term phytotherapy with Canephron N in the treatment regimen increased the effectiveness of treatment, improved kidney function in patients, significantly reduced the number of pregnant women with leukocyturia and bacteriuria, and reduced the risk of a repeated attack of pyelonephritis." 07/01/2018 - "Recurrent bacteriuria was registered in 17 patients from the group of antibiotic therapy and in three in the Canephron N group (p=0.0006). " 07/01/2018 - "[Comparative effectivenesss of standard antibiotic therapy and Canephron N asymptomatic bacteriuria in pregnant women]." 07/01/2018 - "The management of asymptomatic bacteriuria in pregnancy using Canephron N is not inferior to standard antibiotic therapy regarding the incidence of symptomatic infection, premature birth, and low birth weight delivery. "
5.	Urinary Tract Infections (Urinary Tract Infection) 01/01/2018 - "The aim of this observational study was to evaluate the effectiveness of a phytotherapic drug (Canephron N) in preventing urinary tract infection (UTI) in high-risk women undergoing urodynamic studies (UDS). " 10/01/2022 - "A sample size of 144 patients per group was established, to provide at least 90% power to demonstrate the non-inferiority of phytodrug Femistina versus Canephron as a prevention of post-MUS urinary tract infection. " 12/01/2021 - "[The efficiency of combined regimens for the treatment of urinary tract infections in women using the herbal drug Canephron N]." 10/01/2022 - "Femistina versus Canephron as a prevention of urinary tract infections after midurethral sling surgery - Non-inferiority study." 01/01/2023 - "Phytotherapy (BNO 1045) of Acute Lower Uncomplicated Urinary Tract Infection in Women Normalizes Local Host Responses."

Related Drugs and Biologics

1.	Anti-Bacterial Agents (Antibiotics)
2.	Fosfomycin
3.	Tromethamine (Trometamol)
4.	Ciprofloxacin (Cipro)
5.	Plant Preparations (Preparation, Plant)
6.	Urea (Carbamide)
7.	Parasympatholytics (Antispasmodics)
8.	Calcium
9.	cystone

Related Therapies and Procedures

1.	Phytotherapy (Herbal Therapy)
2.	Therapeutics
3.	Suburethral Slings (Tension-Free Vaginal Tape)
4.	Antibiotic Prophylaxis
5.	Lithotripsy (Extracorporeal Shockwave Lithotripsy)